TY - JOUR
T1 - Risk of salmonellosis from consumption of almonds in the North American market
AU - Lambertini, Elisabetta
AU - Danyluk, Michelle D.
AU - Schaffner, Donald W.
AU - Winter, Carl K.
AU - Harris, Linda J.
N1 - Funding Information:
This research was supported by the Center for Produce Safety, Almond Board of California , and the U.S. Food and Drug Administration (Project No. U01-003-572 ). We are thankful for comments and suggestions from Mark Walderhaug and for the editorial assistance of Sylvia Yada.
PY - 2012/3
Y1 - 2012/3
N2 - Salmonellosis outbreaks from consumption of raw almonds in 2001 and 2004 led to regulations that require mandatory treatment of almonds sold in North America to give a minimum 4-log reduction of Salmonella. This study aims to: 1) assess the risk of salmonellosis associated with almond consumption in North America, with current treatments in effect; 2) determine the resilience of the current production system to increases in prevalence or concentration of Salmonella on almonds; 3) assess the impact of treating less than 100% of the crop; and 4) investigate conditions that could explain the number of cases associated with the 2001 outbreak. Risk was assessed using a Monte Carlo simulation, based on an established dose-response relationship. Data for almond amounts sold, Salmonella prevalence and concentration on almonds, storage time and temperature at different handling steps, population reductions during storage at various temperatures and with different treatments, and consumer handling were based on data from published sources and almond industry or academic expert opinion. What-if scenarios were evaluated for Salmonella prevalence varying from 1 to 65%, concentrations of Salmonella varying from 1 to 120. MPN/100. g, and portions of untreated crop varying from 0 to 10%. The estimated incidence of salmonellosis in North America from almonds as currently treated is on average 0.008 cases per billion servings (with an estimated 6.6. billion servings consumed annually). Increases in Salmonella prevalence to 25%, mean concentrations above 25. MPN/100. g, or leaving 0.05% of the crop untreated all resulted in an arithmetic mean risk greater than 1. case/year (with geometric means remaining below 1. case/year for all variables). Assuming 4000. kg at a prevalence of 65% (observed in recalled lots) and an average concentration of 120. MPN/100. g in raw almonds (back calculated from levels in recalled almonds) predicted over the 2800 cases estimated for the 2001 outbreak. Applying a 4-log reduction to these almonds reduced the average number of predicted cases to less than a single case. The current regulation is effective in maintaining the risk of salmonellosis from consumption of almonds below an arithmetic mean of 1. case/year, although significant increases in either prevalence or concentration, or small increases in proportion of untreated almonds would frequently lead to exceeding this threshold.
AB - Salmonellosis outbreaks from consumption of raw almonds in 2001 and 2004 led to regulations that require mandatory treatment of almonds sold in North America to give a minimum 4-log reduction of Salmonella. This study aims to: 1) assess the risk of salmonellosis associated with almond consumption in North America, with current treatments in effect; 2) determine the resilience of the current production system to increases in prevalence or concentration of Salmonella on almonds; 3) assess the impact of treating less than 100% of the crop; and 4) investigate conditions that could explain the number of cases associated with the 2001 outbreak. Risk was assessed using a Monte Carlo simulation, based on an established dose-response relationship. Data for almond amounts sold, Salmonella prevalence and concentration on almonds, storage time and temperature at different handling steps, population reductions during storage at various temperatures and with different treatments, and consumer handling were based on data from published sources and almond industry or academic expert opinion. What-if scenarios were evaluated for Salmonella prevalence varying from 1 to 65%, concentrations of Salmonella varying from 1 to 120. MPN/100. g, and portions of untreated crop varying from 0 to 10%. The estimated incidence of salmonellosis in North America from almonds as currently treated is on average 0.008 cases per billion servings (with an estimated 6.6. billion servings consumed annually). Increases in Salmonella prevalence to 25%, mean concentrations above 25. MPN/100. g, or leaving 0.05% of the crop untreated all resulted in an arithmetic mean risk greater than 1. case/year (with geometric means remaining below 1. case/year for all variables). Assuming 4000. kg at a prevalence of 65% (observed in recalled lots) and an average concentration of 120. MPN/100. g in raw almonds (back calculated from levels in recalled almonds) predicted over the 2800 cases estimated for the 2001 outbreak. Applying a 4-log reduction to these almonds reduced the average number of predicted cases to less than a single case. The current regulation is effective in maintaining the risk of salmonellosis from consumption of almonds below an arithmetic mean of 1. case/year, although significant increases in either prevalence or concentration, or small increases in proportion of untreated almonds would frequently lead to exceeding this threshold.
KW - Almonds
KW - Risk assessment
KW - Salmonella
UR - http://www.scopus.com/inward/record.url?scp=84857406896&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84857406896&partnerID=8YFLogxK
U2 - 10.1016/j.foodres.2011.05.039
DO - 10.1016/j.foodres.2011.05.039
M3 - Article
AN - SCOPUS:84857406896
SN - 0963-9969
VL - 45
SP - 1166
EP - 1174
JO - Food Research International
JF - Food Research International
IS - 2
ER -